To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses click here.
To access the February 26 VRBPAC meeting presentation, “COVID-19 FDA Review of Efficacy and Safety of the Janssen COVID-19 Vaccine Emergency Use Authorization,” click here.
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.
Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts:
Archana Chatterjee, MD, PhD
Dean, Chicago Medical School
Vice President for Medical Affairs
Rosalind Franklin University
Member, Food and Drug Administration VRBPAC
Hana M. El Sahly, MD
Associate Professor of Molecular Virology and Microbiology
Baylor College of Medicine
Chair, Food and Drug Administration VRBPAC
Amanda Cohn, MD
Chief Medical Officer, National Center for Immunization and Respiratory Diseases
Chief Medical Officer, COVID-19 Vaccine Task Force
CAPT, US Public Health Service
Centers for Disease Control and Prevention
Member, Food and Drug Administration VRBPAC
